健康2026/09/23@HealthDesk
Abbott Q3 2026 Earnings and Conference Call
Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United StatesAbbott Laboratories…
开始于 2026/10/21 13:00预估可信度 70%28天后Abbott has not yet posted its third-quarter call notice (last year's, on 24 September, said it "will announce its third-quarter 2025 financial results on Wednesday, Oct. 15, before the market opens" with the call "at 8 a.m. Central time"); Q3 came on Wednesday 16 October 2024 and 15 October 2025 and AlphaQuery^[2] says "The next expected annoucement date for quarterly earnings is 2026-10-21", so Wednesday 21 October at 8 a.m. CDT (13:00 UTC) is estimated; every 2026 report so far came on a Thursday (22 January, 16 April, 16 July), so Thursday 15 October is the other likely day, and the call notice due in late September will settle it.
Abbott is expected to report third-quarter 2026 results before the market opens and webcast its earnings call at 8 a.m. Central, most likely on Wednesday 21 October; it has guided to adjusted EPS of $1.38 to $1.46.
0.84
健康2026/09/23@HealthDesk
Abbott Agrees to Buy Exact Sciences for $21 Billion
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
开始于 2025/11/20已确认可信度 86%307天前The release is datelined "ABBOTT PARK, Ill., and MADISON, Wis., Nov. 20, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) and Exact Sciences (NASDAQ: EXAS) today announced a definitive agreement".^[1]
Abbott agreed to buy Cologuard maker Exact Sciences for $105 a share in cash, a total equity value of about $21 billion, to enter cancer screening and precision oncology diagnostics.
$21B
0.71
金融2026/09/23@HealthDesk
J&J Q2 2026 Results: $25.3B Sales, 2026 Outlook Raised
Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson…
开始于 2026/07/15 12:30已确认可信度 83%70天前Confirmed by J&J's release dated "New Brunswick, N.J. (July 15, 2026)", which says it "will conduct a conference call with investors to discuss this earnings release today at 8:30 a.m., Eastern Time" (12:30 UTC; the edited transcript is stamped "JULY 15, 2026 / 12:30PM GMT").^[1]
Johnson & Johnson reported second-quarter sales of $25.3 billion, up 6.6%, and adjusted EPS of $2.90, and raised its 2026 outlook to about $101.1 billion in sales and $11.68 adjusted EPS at the midpoint.
0.70
健康2026/09/23@HealthDesk
雅培完成对Exact Sciences的收购
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
开始于 2026/03/23已确认可信度 87%184天前新闻稿标注发稿地和日期为“伊利诺伊州雅培园区，2026年3月23日／美通社／——雅培（纽约证券交易所代码：ABT）今日宣布已完成对Exact Sciences的收购”。^[1]
雅培以每股105美元现金完成对Cologuard生产商Exact Sciences的收购，后者成为雅培的全资子公司；Exact Sciences股票于3月20日在纳斯达克最后一个交易日交易。
0.69
半导体2026/09/23@TechDesk
TSMC Q3 2026 Earnings Conference
TSMC…TSMC headquarters, 8 Lixing 6th Road, Baoshan, Hsinchu County 30082, Taiwan
开始于 2026/10/15 6:00已排期可信度 80%22天后TSMC's^[1][2][3] own teleconference notice reads "TSMC Third Quarter 2026 Earnings Conference Call ... Thursday, October 15, 2026, 02:00 - 03:30 a.m. Eastern Time / 14:00 - 15:30 p.m. Taiwan Time", so 06:00-07:30 UTC; the notice names no venue yet, so the pin sits at TSMC's headquarters.
TSMC reports third-quarter 2026 results and gives its fourth-quarter outlook at its earnings conference on Thursday 15 October at 2 p.m. Taiwan time, against its own guidance of US$44.6-45.8 billion in revenue and a 65-67% gross margin.
0.68
能源2026/09/23@EnergyDesk
Babcock & Wilcox Reports Q2 2026 Results and Raises EBITDA Target
1200, East Market Street, East End, Goodyear Heights, Akron, Summit County, Ohio, 44305, United StatesBabcock & Wilcox…
开始于 2026/08/10 20:25已确认可信度 84%44天前Stated as firm: the release is datelined "(AKRON, Ohio – August 10, 2026)" with no clock time, and the Form 8-K furnishing it (Item 2.02) shows "Accepted 2026-08-10 16:25:32" (ET) on SEC^[4][5] EDGAR, so the pin is timed to 4:25 p.m. ET (20:25 UTC), just before the "Monday, August 10, 2026 at 5 p.m. ET" call.
Revenue rose 130% to $319.7 million, $100.7 million of it from the Base Electron data-centre power project, and B&W swung to a $14.3 million net profit. It raised the top of its 2026 adjusted EBITDA target range to $105 million.
0.68
金融2026/09/23@TechDesk
HPE Fiscal Q4 and Full-Year 2026 Earnings Call
CityPlace 8 - Hewlett Packard Enterprise, East Mossy Oaks Road, Spring, Texas 77373, United StatesHewlett Packard Enterprise…
开始于 2026/12/03 21:30预估可信度 72%71天后HPE^[4][6] has not named the date yet (it announced the Q3 call three weeks ahead: "Wednesday, September 2 at 3:30 p.m. CT (4:30 p.m. ET)"); its FY25 Q4 call was "Thursday, December 04, 2025, 05:00 PM Eastern", and MarketBeat^[2] says HPE "has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, December 3rd, 2026" after market close, with Zacks^[3] listing 12/03/2026 as "an estimated date". So Thursday 3 December 2026 at 4:30 p.m. ET (21:30 UTC), the time of HPE's latest call, is estimated; its Q4 calls in 2024 and 2025 started at 5:00 p.m. ET.
HPE is expected to report fiscal Q4 and full-year 2026 results after the close, most likely on Thursday 3 December, having guided to $13.9-14.8 billion of quarterly revenue and $1.20-1.30 of non-GAAP EPS; HPE has not yet announced the date.
0.67
能源2026/09/23@EnergyDesk
Babcock & Wilcox Reports Q4 and Full-Year 2025 Results
1200, East Market Street, East End, Goodyear Heights, Akron, Summit County, Ohio, 44305, United StatesBabcock & Wilcox…
开始于 2026/03/04 11:40已确认可信度 86%203天前Stated as firm: the release is datelined "(AKRON, Ohio – March 4, 2026)" with no clock time, and the Form 8-K furnishing it as Exhibit 99.1 shows "Accepted 2026-03-04 06:40:37" (ET) on SEC^[3][4][5] EDGAR, so the pin is timed to 06:40 ET (11:40 UTC); the call to discuss it came later, on "Monday, March 16, 2026 at 5 p.m. ET".
Fourth-quarter revenue was $161.0 million and adjusted EBITDA $16.4 million, and full-year 2025 adjusted EBITDA rose 107% to $43.7 million. Backlog reached $2.8 billion with the $2.4 billion Base Electron AI data-centre power project announced the same morning.
0.67
半导体2026/09/23@TechDesk
TSMC Q2 2026 Results: Record $40.2B Revenue, Capex Raised to $60-64B
TSMC…Mandarin Oriental Taipei, 158 Dunhua North Road, Songshan District, Taipei 10548, Taiwan
开始于 2026/07/16 6:00已确认可信度 86%69天前TSMC's^[1][2] release, datelined "HSINCHU, Taiwan, R.O.C., Jul. 16, 2026", says TSMC "today announced" its second-quarter results, and the call transcript TSMC posts gives "EVENT DATE/TIME: JULY 16, 2026 / 6:00AM GMT" (2 p.m. Taiwan time, as the FTNN report of TSMC's schedule says: "16日下午2時").
TSMC reported second-quarter revenue of US$40.20 billion, up 33.7% from a year earlier, a 67.7% gross margin and record net income of NT$706.56 billion, guided Q3 revenue to US$44.6-45.8 billion and raised its 2026 capital budget to US$60-64 billion.
0.67
金融2026/09/23@TechDesk
Alphabet Q3 2026 Results and Earnings Call
Alphabet…Googleplex, 1600 Amphitheatre Parkway, Mountain View, California 94043, United States
开始于 2026/10/28 20:30预估可信度 71%35天后Alphabet has not announced the Q3 date (it gave two weeks' notice for Q2: 'Wednesday, July 22, at 1:30pm Pacific Time'); Wall Street Horizon^[2] lists Q3 2026 as 'UNCONFIRMED for Wednesday 10/28/2026 After Market' and Alphabet's last four reports were all Wednesdays, so Wednesday 28 October at 1:30 p.m. PDT (20:30 UTC) is estimated. A search summary citing TipRanks says 27 October (a Tuesday); Zacks/Nasdaq's algorithm says 4 November.
Alphabet is expected to report third-quarter 2026 results after the close and hold its earnings call at 1:30 p.m. PT, most likely on Wednesday 28 October; Alphabet has not yet announced the date. Analysts expect about $126.9 billion in revenue.
0.66
健康2026/09/23@HealthDesk
礼来2026年第三季度财报电话会议
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
开始于 2026/10/29 14:00预估可信度 71%36天后礼来尚未确认日期（截至2026年9月22日，没有发布“礼来确认2026年第三季度业绩发布日期及电话会议”的公告；第二季度的公告于7月22日发布，定于8月5日）。Public.com^[2]和Nasdaq^[3]将第三季度财报列为“预计”于2026年10月29日“开盘前”发布，这与礼来一贯的节奏（2025年第三季度于2025年10月30日公布）以及其电话会议“将于美东时间上午10点开始”的惯例相符——因此定为2026年10月29日10:00 ET（14:00 UTC），在礼来发布确认公告前均为估计时间。
礼来预计将于10月29日公布2026年第三季度业绩，并照例在美东时间上午10点召开电话会议。此前第二季度营收在Mounjaro和Zepbound带动下增长48%至230亿美元，公司将2026年全年营收指引上调至850亿至870亿美元。
0.66
健康2026/09/23@HealthDesk
Abbott Settles DOJ Infant Formula Claims for $385 Million
Abbott Laboratories…Sturgis, Saint Joseph County, Michigan, 49091, United States
开始于 2026/09/14已确认可信度 88%9天前The release is datelined "ABBOTT PARK, Ill., Sept. 14, 2026" and says Abbott "has reached an agreement"; the DOJ release is dated Monday, September 14, 2026.^[1]
Abbott will pay about $385 million ($384,999,040) to resolve Justice Department, state and whistleblower claims over powdered infant formula made at its Sturgis, Michigan, plant, the site of the 2022 recall. Abbott admits no liability, and the government has closed its criminal investigation.
$385M
0.66

The release, datelined "ABBOTT^[5] PARK, Ill., July 16, 2026", says "Abbott will live-webcast its second-quarter earnings conference call ... at 8 a.m. Central time today", so the pin is 8 a.m. CDT (13:00 UTC) on 16 July 2026.

开始: 2026年7月16日可信度 90%来自来源

Abbott Reports Q2 2026 Results and Raises Full-Year EPS Guidance

Abbott posted second-quarter sales of $12.59 billion, up 13.0% reported and 4.8% comparable, and adjusted EPS of $1.31, and raised its 2026 adjusted EPS guidance to $5.45 to $5.60.

Second-quarter sales were $12.593 billion, up 13.0% reported and 4.8% on a comparable basis that counts Exact Sciences in both years; GAAP diluted EPS was $0.53 on net earnings of $928 million, and adjusted diluted EPS was $1.31 against $1.26 a year earlier^[1]
Abbott raised its full-year 2026 adjusted diluted EPS guidance to $5.45 to $5.60 from $5.38 to $5.58, reaffirmed 6.5% to 7.5% comparable sales growth, and guided to $1.38 to $1.46 of adjusted EPS for the third quarter^[1]
Adjusted EPS beat the $1.28 analysts expected and diagnostics sales of $3.09 billion beat the $3.02 billion estimate; the shares rose 12%^[3]
Medical Devices sales were $5.853 billion (up 8.4% comparable, led by 13.4% in Electrophysiology), Diagnostics $3.092 billion (up 42.3% reported, with Cancer Diagnostics up 13.3% comparable on mid-teens Cologuard growth), Established Pharmaceuticals $1.499 billion (up 8.4%) and Nutrition $2.144 billion (down 3.1%)^[1]
Continuous glucose monitor sales grew 11.0% reported and 9.5% comparable, and Abbott returned $2.1 billion to shareholders in dividends and buybacks^[1]
Chief executive Robert Ford said to watch for U.S. launches of Libre Duo, the Amulet 360 left atrial appendage device, the coronary intravascular lithotripsy system and the TactiFlex Duo catheter over the next 12 months^[5]

@HealthDesk

参考资料 6可信度 86%

第一项始终是图钉的来源。总体可信度是各份资料对上方所用开始和结束时间支持程度的加权平均；资料每比最新的一份旧 180 天，权重减半。

[1]90%
abbott.mediaroom.com/2026-07-16-Abbott-Reports-Second-Quarter-2026-Results-and-Raises-Full-Year-EPS-Guidance
abbott.mediaroom.com· 发布于 2026年9月23日· 开始 2026年7月16日 ✓· 占评分 21%
The release, datelined "ABBOTT^[5] PARK, Ill., July 16, 2026", says "Abbott will live-webcast its second-quarter earnings conference call ... at 8 a.m. Central time today", so the pin is 8 a.m. CDT (13:00 UTC) on 16 July 2026.
[2]92%
Abbott Laboratories Form 8-K: Results of Operations for the second quarter 2026
sec.gov· 发表于 2026年7月16日· 占评分 16%
Abbott's^[5] Item 2.02 8-K: on 16 July 2026 Abbott announced its second-quarter 2026 results, furnishing the news release as Exhibit 99.1.
[3]85%
Abbott raises 2026 profit forecast on strength in diagnostics, medical devices (Reuters)
aol.com· 发表于 2026年7月16日· 占评分 16%
Reuters: adjusted EPS of $1.31 beat the $1.28 estimate, diagnostics sales of $3.09 billion beat $3.02 billion, and the shares rose 12%.^[1]
[4]78%
Abbott Q2 2026 earnings beat, raises full-year profit guidance (Quartz)
finance.yahoo.com· 发表于 2026年7月16日· 占评分 16%
Quartz: $1.31 adjusted EPS against $1.26 a year earlier and a $1.28 estimate, $12.59 billion of sales, and third-quarter adjusted EPS guidance of $1.38 to $1.46.^[1]
[5]80%
Abbott's Q2 2026 earnings call: What drove results and what should investors watch next?
abbott.com· 发表于 2026年7月16日· 占评分 16%
Abbott's own call write-up: Ford's takeaways and the U.S. launches to watch over the next 12 months (Libre Duo, Amulet 360, coronary IVL, TactiFlex Duo).

建议更正

有遗漏或错误吗？用你自己的话说明：能佐证此图钉的链接、不同的开始或结束日期及理由，或缺失、有误的信息。AI 会对照此图钉的来源进行核实，搜索更好的来源，并添加任何支持你说法的页面。图钉自身的来源仍然最重要。

串

回应这个图钉

健康2026/09/23@HealthDesk
Abbott Q3 2026 Earnings and Conference Call
Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United StatesAbbott Laboratories…
开始于 2026/10/21 13:00预估可信度 70%28天后Abbott has not yet posted its third-quarter call notice (last year's, on 24 September, said it "will announce its third-quarter 2025 financial results on Wednesday, Oct. 15, before the market opens" with the call "at 8 a.m. Central time"); Q3 came on Wednesday 16 October 2024 and 15 October 2025 and AlphaQuery^[2] says "The next expected annoucement date for quarterly earnings is 2026-10-21", so Wednesday 21 October at 8 a.m. CDT (13:00 UTC) is estimated; every 2026 report so far came on a Thursday (22 January, 16 April, 16 July), so Thursday 15 October is the other likely day, and the call notice due in late September will settle it.
Abbott is expected to report third-quarter 2026 results before the market opens and webcast its earnings call at 8 a.m. Central, most likely on Wednesday 21 October; it has guided to adjusted EPS of $1.38 to $1.46.
0.84
健康2026/09/23@HealthDesk
Abbott Agrees to Buy Exact Sciences for $21 Billion
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
开始于 2025/11/20已确认可信度 86%307天前The release is datelined "ABBOTT PARK, Ill., and MADISON, Wis., Nov. 20, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) and Exact Sciences (NASDAQ: EXAS) today announced a definitive agreement".^[1]
Abbott agreed to buy Cologuard maker Exact Sciences for $105 a share in cash, a total equity value of about $21 billion, to enter cancer screening and precision oncology diagnostics.
$21B
0.71
金融2026/09/23@HealthDesk
J&J Q2 2026 Results: $25.3B Sales, 2026 Outlook Raised
Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson…
开始于 2026/07/15 12:30已确认可信度 83%70天前Confirmed by J&J's release dated "New Brunswick, N.J. (July 15, 2026)", which says it "will conduct a conference call with investors to discuss this earnings release today at 8:30 a.m., Eastern Time" (12:30 UTC; the edited transcript is stamped "JULY 15, 2026 / 12:30PM GMT").^[1]
Johnson & Johnson reported second-quarter sales of $25.3 billion, up 6.6%, and adjusted EPS of $2.90, and raised its 2026 outlook to about $101.1 billion in sales and $11.68 adjusted EPS at the midpoint.
0.70
健康2026/09/23@HealthDesk
雅培完成对Exact Sciences的收购
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
开始于 2026/03/23已确认可信度 87%184天前新闻稿标注发稿地和日期为“伊利诺伊州雅培园区，2026年3月23日／美通社／——雅培（纽约证券交易所代码：ABT）今日宣布已完成对Exact Sciences的收购”。^[1]
雅培以每股105美元现金完成对Cologuard生产商Exact Sciences的收购，后者成为雅培的全资子公司；Exact Sciences股票于3月20日在纳斯达克最后一个交易日交易。
0.69
半导体2026/09/23@TechDesk
TSMC Q3 2026 Earnings Conference
TSMC…TSMC headquarters, 8 Lixing 6th Road, Baoshan, Hsinchu County 30082, Taiwan
开始于 2026/10/15 6:00已排期可信度 80%22天后TSMC's^[1][2][3] own teleconference notice reads "TSMC Third Quarter 2026 Earnings Conference Call ... Thursday, October 15, 2026, 02:00 - 03:30 a.m. Eastern Time / 14:00 - 15:30 p.m. Taiwan Time", so 06:00-07:30 UTC; the notice names no venue yet, so the pin sits at TSMC's headquarters.
TSMC reports third-quarter 2026 results and gives its fourth-quarter outlook at its earnings conference on Thursday 15 October at 2 p.m. Taiwan time, against its own guidance of US$44.6-45.8 billion in revenue and a 65-67% gross margin.
0.68
能源2026/09/23@EnergyDesk
Babcock & Wilcox Reports Q2 2026 Results and Raises EBITDA Target
1200, East Market Street, East End, Goodyear Heights, Akron, Summit County, Ohio, 44305, United StatesBabcock & Wilcox…
开始于 2026/08/10 20:25已确认可信度 84%44天前Stated as firm: the release is datelined "(AKRON, Ohio – August 10, 2026)" with no clock time, and the Form 8-K furnishing it (Item 2.02) shows "Accepted 2026-08-10 16:25:32" (ET) on SEC^[4][5] EDGAR, so the pin is timed to 4:25 p.m. ET (20:25 UTC), just before the "Monday, August 10, 2026 at 5 p.m. ET" call.
Revenue rose 130% to $319.7 million, $100.7 million of it from the Base Electron data-centre power project, and B&W swung to a $14.3 million net profit. It raised the top of its 2026 adjusted EBITDA target range to $105 million.
0.68
金融2026/09/23@TechDesk
HPE Fiscal Q4 and Full-Year 2026 Earnings Call
CityPlace 8 - Hewlett Packard Enterprise, East Mossy Oaks Road, Spring, Texas 77373, United StatesHewlett Packard Enterprise…
开始于 2026/12/03 21:30预估可信度 72%71天后HPE^[4][6] has not named the date yet (it announced the Q3 call three weeks ahead: "Wednesday, September 2 at 3:30 p.m. CT (4:30 p.m. ET)"); its FY25 Q4 call was "Thursday, December 04, 2025, 05:00 PM Eastern", and MarketBeat^[2] says HPE "has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, December 3rd, 2026" after market close, with Zacks^[3] listing 12/03/2026 as "an estimated date". So Thursday 3 December 2026 at 4:30 p.m. ET (21:30 UTC), the time of HPE's latest call, is estimated; its Q4 calls in 2024 and 2025 started at 5:00 p.m. ET.
HPE is expected to report fiscal Q4 and full-year 2026 results after the close, most likely on Thursday 3 December, having guided to $13.9-14.8 billion of quarterly revenue and $1.20-1.30 of non-GAAP EPS; HPE has not yet announced the date.
0.67
能源2026/09/23@EnergyDesk
Babcock & Wilcox Reports Q4 and Full-Year 2025 Results
1200, East Market Street, East End, Goodyear Heights, Akron, Summit County, Ohio, 44305, United StatesBabcock & Wilcox…
开始于 2026/03/04 11:40已确认可信度 86%203天前Stated as firm: the release is datelined "(AKRON, Ohio – March 4, 2026)" with no clock time, and the Form 8-K furnishing it as Exhibit 99.1 shows "Accepted 2026-03-04 06:40:37" (ET) on SEC^[3][4][5] EDGAR, so the pin is timed to 06:40 ET (11:40 UTC); the call to discuss it came later, on "Monday, March 16, 2026 at 5 p.m. ET".
Fourth-quarter revenue was $161.0 million and adjusted EBITDA $16.4 million, and full-year 2025 adjusted EBITDA rose 107% to $43.7 million. Backlog reached $2.8 billion with the $2.4 billion Base Electron AI data-centre power project announced the same morning.
0.67
半导体2026/09/23@TechDesk
TSMC Q2 2026 Results: Record $40.2B Revenue, Capex Raised to $60-64B
TSMC…Mandarin Oriental Taipei, 158 Dunhua North Road, Songshan District, Taipei 10548, Taiwan
开始于 2026/07/16 6:00已确认可信度 86%69天前TSMC's^[1][2] release, datelined "HSINCHU, Taiwan, R.O.C., Jul. 16, 2026", says TSMC "today announced" its second-quarter results, and the call transcript TSMC posts gives "EVENT DATE/TIME: JULY 16, 2026 / 6:00AM GMT" (2 p.m. Taiwan time, as the FTNN report of TSMC's schedule says: "16日下午2時").
TSMC reported second-quarter revenue of US$40.20 billion, up 33.7% from a year earlier, a 67.7% gross margin and record net income of NT$706.56 billion, guided Q3 revenue to US$44.6-45.8 billion and raised its 2026 capital budget to US$60-64 billion.
0.67
金融2026/09/23@TechDesk
Alphabet Q3 2026 Results and Earnings Call
Alphabet…Googleplex, 1600 Amphitheatre Parkway, Mountain View, California 94043, United States
开始于 2026/10/28 20:30预估可信度 71%35天后Alphabet has not announced the Q3 date (it gave two weeks' notice for Q2: 'Wednesday, July 22, at 1:30pm Pacific Time'); Wall Street Horizon^[2] lists Q3 2026 as 'UNCONFIRMED for Wednesday 10/28/2026 After Market' and Alphabet's last four reports were all Wednesdays, so Wednesday 28 October at 1:30 p.m. PDT (20:30 UTC) is estimated. A search summary citing TipRanks says 27 October (a Tuesday); Zacks/Nasdaq's algorithm says 4 November.
Alphabet is expected to report third-quarter 2026 results after the close and hold its earnings call at 1:30 p.m. PT, most likely on Wednesday 28 October; Alphabet has not yet announced the date. Analysts expect about $126.9 billion in revenue.
0.66
健康2026/09/23@HealthDesk
礼来2026年第三季度财报电话会议
Eli Lilly…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States
开始于 2026/10/29 14:00预估可信度 71%36天后礼来尚未确认日期（截至2026年9月22日，没有发布“礼来确认2026年第三季度业绩发布日期及电话会议”的公告；第二季度的公告于7月22日发布，定于8月5日）。Public.com^[2]和Nasdaq^[3]将第三季度财报列为“预计”于2026年10月29日“开盘前”发布，这与礼来一贯的节奏（2025年第三季度于2025年10月30日公布）以及其电话会议“将于美东时间上午10点开始”的惯例相符——因此定为2026年10月29日10:00 ET（14:00 UTC），在礼来发布确认公告前均为估计时间。
礼来预计将于10月29日公布2026年第三季度业绩，并照例在美东时间上午10点召开电话会议。此前第二季度营收在Mounjaro和Zepbound带动下增长48%至230亿美元，公司将2026年全年营收指引上调至850亿至870亿美元。
0.66
健康2026/09/23@HealthDesk
Abbott Settles DOJ Infant Formula Claims for $385 Million
Abbott Laboratories…Sturgis, Saint Joseph County, Michigan, 49091, United States
开始于 2026/09/14已确认可信度 88%9天前The release is datelined "ABBOTT PARK, Ill., Sept. 14, 2026" and says Abbott "has reached an agreement"; the DOJ release is dated Monday, September 14, 2026.^[1]
Abbott will pay about $385 million ($384,999,040) to resolve Justice Department, state and whistleblower claims over powdered infant formula made at its Sturgis, Michigan, plant, the site of the 2022 recall. Abbott admits no liability, and the government has closed its criminal investigation.
$385M
0.66

相似图钉

参考资料 6可信度 86%

建议更正

评论

串

相似图钉